Navigation Links
PCBs Might Be Linked to Failed IVF Attempts
Date:2/24/2011

By Steven Reinberg
HealthDay Reporter

THURSDAY, Feb. 24 (HealthDay News) -- Although polychlorinated biphenyls (PCBs) were banned decades ago, they are still pervasive in the United States and may contribute to failed in vitro fertilization (IVF) attempts, a new study suggests.

In fact, PCBs may account for a 40 percent reduced chance of a live birth after IVF, the researchers said.

"These findings may help explain why these chemicals were associated with fertility issues in other studies," said lead researcher John Meeker, an assistant professor of environmental health sciences at the University of Michigan School of Public Health.

Meeker noted that there is not much women can do to avoid PCBs, since they are still found in seafood and dairy foods.

"Levels of PCBs have been declining gradually over the past couple of decades, but when or if these levels reach zero isn't known," he said.

The report is published in the Feb. 24 online issue of Environmental Health Perspectives.

For the study, Meeker's team collected data on IVF attempts of 765 women. In addition, they tested blood samples for 57 different PCBs.

Among these women, 286 gave birth, but 530 lost their babies, the researchers found. Of those who lost their baby, 229 had implantation failures and 301 had miscarriages.

Specifically, Meeker's group looked at blood levels of PCBs called congeners 118, 138 and 153, along with total PCB exposure.

They found that women with the highest levels of PCB 153 and total PCBs had twice the risk of implantation failure, compared with women with the lowest levels.

Moreover, women with the highest levels of these chemicals were 40 percent less likely to give birth, they added.

Meeker's team noted that these data may not apply to couples not using IVF, and may vary due to factors not accounted for in the woman's partner.

Commenting on the study, Dr. George R. Attia, director of the division of reproductive endocrinology and infertility at the University of Miami Miller School of Medicine, said that "I'm not really convinced."

"This study did not show a cause-and-effect relationship between PCBs and these outcomes," he said. "We cannot say it doesn't, but neither can we say PCBs have a cause-and-effect relationship either."

Attia did not say women should not be concerned about PCB exposure, but studies that look for a cause-and-effect relationship are needed to prove the connection between these chemicals and adverse IVF outcomes, he explained.

Although PCBs, which were compounds used in industrial materials, were banned in the United States and other countries in the 1970s, they still persist due to widespread use and resistance to breakdown. Exposure to PCBs occurs mostly through foods and they have been linked with reproductive problems, Meeker said.

More information

For more information on the health effects of PCBs, visit the U.S. Environmental Protection Agency.

SOURCES: John Meeker, Sc.D., assistant professor, environmental health sciences, University of Michigan School of Public Health, Ann Arbor; George R. Attia, M.D., associate professor, clinical obstetrics and gynecology, and director, division of reproductive endocrinology and infertility, University of Miami Miller School of Medicine; Feb. 24, 2011, Environmental Health Perspectives, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Statins Might Help HIV Patients, Study Suggests
2. Early Childhood Might Affect Love Life in Adult
3. Laser Technology Might Help Doctors Diagnose Melanoma
4. Nitroglycerin Ointment Might Strengthen Bones
5. Speaking Several Languages Might Protect Memory
6. Simple spit and blood tests might detect burnout before it happens
7. Education Might Help Kidney Recipients Spot Skin Cancer
8. That Squeaking Sound Might Come From Your New Hip
9. Using Cell Phones Might Evoke Emotions, Study Suggests
10. Leg Discomfort Might Signal Heart Trouble
11. Diet High in Fiber Might Lengthen Your Life
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
PCBs Might Be Linked to Failed IVF Attempts
(Date:4/25/2017)... ... , ... Vetoquinol USA® , a world-class developer of ... the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin ... , The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and ...
(Date:4/24/2017)... ORLANDO, FLORIDA (PRWEB) , ... April 24, 2017 ... ... of telehealth technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth ... compliment LG CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed ...
(Date:4/24/2017)... ... 24, 2017 , ... Ridgecrest Herbals makes it a point to lead the ... waste, and support renewable energy. They believe this is a crucial part of their ... for health issues, and maintain that destroying the environment in the pursuit of profit ...
(Date:4/24/2017)... ... April 24, 2017 , ... The bar for just about everything—apparel, ... inhabiting the rarified air of pop and film stardom.(1) Not to be left out ... the smile. Grins now run the gamut from being encrusted with jewels and precious ...
(Date:4/24/2017)... Washington (PRWEB) , ... April 24, 2017 , ... Sean ... OptiGrill, Oxiclean, Space Bag, Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill (which ... perhaps any other marketer in the last 25 years. , Now, due to changes ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... Research and Markets has announced the addition ... Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during ... ... rise from USD 20 Billion in 2015 to around USD 26 ... - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage ...
(Date:4/20/2017)... --  ZappRx, Inc ., a digital health company focused on ... it closed $25 million in Series B funding led by ... Seattle that is part of a ... B round included participation from SR One , who ... (formerly Google Ventures). As part of the financing, ...
Breaking Medicine Technology: